Xifaxan (Rifaximin)
rifaximin 550 mg tablet, 56 · ORAL · PBS code 10001J
AUTHORITY_REQUIREDWhat it costs
AU$394.14 PBS-determined price per 56 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2013-12-01.
- • Repeats: 5.
- • PBS program: GE.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Prevention of hepatic encephalopathy
Must be treated by a gastroenterologist or hepatologist or in consultation with a gastroenterologist or hepatologist; AND
The treatment must be in combination with lactulose, if lactulose is tolerated; AND
Patient must have had prior episodes of hepatic encephalopathy.
Sponsor: Norgine Pty. Ltd. ABN 78 005 022 882
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.